LG to export technologies of new drug for B viral hepatitis.

Published: 2004-04-20 08:09:00

Updated: 2004-04-20 08:09:00

LG Life Science Co. has developed a new drug for the treatment of B viral hepatitis under the code of B80380 and tried to explore a strategic business tie-up with Anadys Corp. of America for an earlier commercialization in the world market.
For this purpose LG Life Science has made an agreement with Anadys for the technology licensing at the total U$30 million of royalty, the joint R&D and the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.